Elevance Health, Inc.
ELV
$289.10
$8.673.09%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.74B | 2.18B | 418.00M | 1.02B | 2.30B |
| Total Depreciation and Amortization | 380.00M | 373.00M | -336.00M | 329.00M | 335.00M |
| Total Amortization of Deferred Charges | -- | -- | 734.00M | -- | -- |
| Total Other Non-Cash Items | 149.00M | 246.00M | -92.00M | 90.00M | -233.00M |
| Change in Net Operating Assets | -218.00M | -1.79B | -18.00M | 1.24B | -1.96B |
| Cash from Operations | 2.05B | 1.02B | 706.00M | 2.68B | 447.00M |
| Capital Expenditure | -267.00M | -196.00M | -322.00M | -332.00M | -323.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 54.00M | -- | -3.69B | 0.00 | -4.00M |
| Divestitures | -4.00M | 4.00M | -36.00M | 0.00 | 399.00M |
| Other Investing Activities | -470.00M | 295.00M | 2.41B | -69.00M | -890.00M |
| Cash from Investing | -687.00M | 103.00M | -1.64B | -401.00M | -818.00M |
| Total Debt Issued | 261.00M | 836.00M | 5.04B | 48.00M | 1.34B |
| Total Debt Repaid | 110.00M | -1.37B | -1.45B | -568.00M | 107.00M |
| Issuance of Common Stock | -- | 23.00M | 16.00M | 48.00M | 60.00M |
| Repurchase of Common Stock | -297.00M | -1.00B | -1.81B | -66.00M | -463.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -385.00M | -386.00M | -373.00M | -378.00M | -378.00M |
| Other Financing Activities | 3.00M | -14.00M | -7.00M | 1.00M | 4.00M |
| Cash from Financing | -308.00M | -1.91B | 1.41B | -915.00M | 668.00M |
| Foreign Exchange rate Adjustments | 1.00M | 1.00M | -8.00M | 7.00M | -5.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -46.00M | 1.00M | -21.00M |
| Net Change in Cash | 1.06B | -788.00M | 422.00M | 1.37B | 271.00M |